Veru Inc logo

VERU - Veru Inc Share Price

$12.43 0.1  0.8%

Last Trade - 08/03/21

Sector
Consumer Defensives
Size
Mid Cap
Market Cap £698.0m
Enterprise Value £685.3m
Revenue £33.7m
Position in Universe 2807th / 6647
Bullish
Bearish
Unlock VERU Revenue
Momentum
Relative Strength (%)
1m +28.1%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -49.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
32.6 22.1 13.7 15.9 31.8 42.6 59.9 72.7 +5.5%
+78.3 -69.9
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 December 2020, VeruInc revenues increased 38% to $14.6M. Net income totaled$17.2M vs. loss of $3.3M. Revenues reflect United Statessegment increase of 60% to $10.4M, Other Countries segmentincrease of 72% to $4.3M. Net Income reflects Corporatesegment income totaling $15.1M vs. loss of $2.3M,Commercial segment income increase of 71% to $9.9M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for VERU
Graphical History

Revenue

VERU Revenue Unlock VERU Revenue

Net Income

VERU Net Income Unlock VERU Revenue

Normalised EPS

VERU Normalised EPS Unlock VERU Revenue

PE Ratio Range

VERU PE Ratio Range Unlock VERU Revenue

Dividend Yield Range

VERU Dividend Yield Range Unlock VERU Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
VERU EPS Forecasts Unlock VERU Revenue
Profile Summary

Veru Inc. is an oncology and urology biopharmaceutical company with a focus on developing medicines for the management of prostate cancer. The Company operates in two segments: Commercial and Research, and Development. The Commercial segment consists of FC2. The Research and Development segment consists of multiple drug products under clinical development for oncology and urology. The Company's prostate cancer pipeline includes VERU-111, VERU-100 and Zuclomiphene Citrate. VERU-111 is an oral chemical entity that targets, crosslinks, and disrupts alpha and beta tubulin subunits of microtubules. VERU-100 is a peptide formulation designed to address the limitations of commercially available androgen deprivation therapies (ADT) for advanced prostate cancer. The Company's commercial products include FC2 Female Condom/FC2 Internal Condom (FC2), a product for the protection against unintended pregnancy and sexually transmitted infections.

Directors
Last Annual September 30th, 2020
Last Interim December 31st, 2020
Incorporated February 4, 1971
Public Since July 19, 1990
No. of Shareholders: n/a
No. of Employees: 339
Sector Consumer Defensives
Industry Personal & Household Products & Services
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 78,358,516
Free Float (0.0%)
Eligible for
ISAs
SIPPs
VERU Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for VERU
Upcoming Events for VERU
Frequently Asked Questions for Veru Inc
What is the Veru Inc share price?

As of 08/03/21, shares in Veru Inc are trading at $12.43, giving the company a market capitalisation of £698.0m. This share price information is delayed by 15 minutes.

How has the Veru Inc share price performed this year?

Shares in Veru Inc are currently trading at $12.43 and the price has moved by 0.215k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Veru Inc price has moved by 0.149k% over the past year.

What are the analyst and broker recommendations for Veru Inc?

Of the analysts with advisory recommendations for Veru Inc, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Veru Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Veru Inc next release its financial results?

Veru Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Veru Inc dividend yield?

Veru Inc does not currently pay a dividend.

Does Veru Inc pay a dividend?

Veru Inc does not currently pay a dividend.

When does Veru Inc next pay dividends?

Veru Inc does not currently pay a dividend.

How do I buy Veru Inc shares?

To buy shares in Veru Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Veru Inc?

Shares in Veru Inc are currently trading at $12.43, giving the company a market capitalisation of £698.0m.

Where are Veru Inc shares listed? Where are Veru Inc shares listed?

Here are the trading details for Veru Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: VERU
What kind of share is Veru Inc?

Based on an overall assessment of its quality, value and momentum, Veru Inc is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Veru Inc share price forecast 2021?

Shares in Veru Inc are currently priced at $12.43. At that level they are trading at 0.101% discount to the analyst consensus target price of 0.00.

Analysts covering Veru Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.023 for the next financial year.

How can I tell whether the Veru Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Veru Inc. Over the past six months, the relative strength of its shares against the market has been 0.305k%. At the current price of $12.43, shares in Veru Inc are trading at 0.128k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Veru Inc PE Ratio?

We were not able to find PE ratio data for Veru Inc.

Who are the key directors of Veru Inc?

Veru Inc's management team is headed by:

Michele Greco - CFO
Mitchell Steiner - CHM
Harry Fisch - VCH
Mario Eisenberger - IND
K. Barnette - CSO
Jesus Socorro - IND
Michael Rankowitz - IND
Grace Hyun - IND
Who are the major shareholders of Veru Inc?

Here are the top five shareholders of Veru Inc based on the size of their shareholding:

Fisch (Harry) Individual Investor
Percentage owned: 10.34% (8.10m shares)
Steiner (Mitchell Shuster) Individual Investor
Percentage owned: 9.44% (7.39m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 4.69% (3.67m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.41% (3.45m shares)
Perceptive Advisors LLC Private Equity
Percentage owned: 4.15% (3.25m shares)
Similar to VERU
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.